Pictured above, UC Berkeley Amgen Scholar Melissa Velasquez in Dr. Kevin Healy’s lab with postdoctoral student Jacob Pollock.

81
EUROPE
U.S.
2007 2008 2009
NUMBER OF COLLEGES AND UNIVERSITIES REPRESENTED
BY AMGEN SCHOLAR APPLICANTS
255
EUROPE
2007 2008 2009
NUMBER OF AMGEN SCHOLAR APPLICANTS
U.S.
323
EUROPE
“There is a single light of science, and to brighten it anywhere is to brighten it everywhere.” So wrote Isaac Asimov, one of the twentieth century’s finest science writers.
The Amgen Scholars Program was founded to ensure that today’s undergraduates have the opportunity to discover their potential to contribute to the light that science casts; three years later, it is clear that the program has been hugely successful in this aim. Those whom we have welcomed as Amgen Scholars have impressed us all with their energy and enthusiasm for science, and with the way in which they have grasped the opportunities provided through the program with both hands.
Many of the program’s alumni are already taking the first steps toward a research career of their own, winning prestigious scholarships and awards along the way. We will continue to watch with pride as the discoveries they make help to brighten the light of science across a wide range of disciplines.
On top of the continued success of the 10 U.S. program sites, the past year has been an exciting one for the Amgen Scholars Program as we welcomed the first cohort of Amgen Scholars in Europe. The addition of the Karolinska Institutet in Stockholm, Sweden; Ludwig-Maximilians-
Universität in Munich, Germany; and the University of Cambridge in the
United Kingdom as program sites has enabled us to reach many more of the potential scientific leaders of tomorrow, and provides a truly international dimension to the program. Together, all 13 sites make this a premier program around the globe.
As of late 2009, we were also excited to announce the launch of our new program website which is enabling all our Scholars, past and present, to continue to use and build on the networks they have developed during the program, and create new ones, and the internationality of our alumni can only help in that regard.
We expect that the incoming year will be another exciting one for the program and everyone involved. As always, we endeavor to build on past successes, and to ensure that the program continues to raise the scientific aspirations of all those who participate. In 2010, we look forward to welcoming another group of exceptional young scientists as
Amgen Scholars, and to supporting them, and all our alumni, as they strive to brighten the light of science on an international scale.
U.S.
2007 2008 2009
NUMBER OF AMGEN SCHOLAR APPLICATIONS*
*NOTE: Applicants may apply to multiple Amgen Scholar host institutions.
Tony Minson
Director, Amgen Scholars
European Coordinating Center
University of Cambridge
Christopher M. Jones
Director, Amgen Scholars
U.S. Program Office
Massachusetts Institute of Technology
1

2
Biotechnology is based on biology, which is the study of life. The basic unit of life is the cell. Biologists study the structure and functions of cells – what cells do and how they do it. Biotechnologists use this information to develop products.
Biomedical researchers use their understanding of genes, proteins and cell parts to pinpoint the differences between diseased and healthy cells. When researchers know how diseased cells are altered and when they learn how to affect those alterations, they are better able to develop innovative medical diagnostics, devices and therapies.
The biotechnology industry uses advanced technologies to apply cellular and molecular biology to create new, beneficial products. Medical biotechnology products are used to treat or prevent diseases. These products include therapeutic proteins, monoclonal antibodies, vaccines, allergy immunotherapy products, blood components, and tissues and cells for transplantation.
In addition to these biotechnology products, which have offered new treatment options to millions of patients, new, innovative diagnostics and therapies are changing how some human diseases are prevented and others are treated. This monumental healthcare shift is in its early stages, with novel medicines, diagnostics and technologies in development that hold great potential to improve patients’ lives.
The practice of medicine has changed dramatically over the years through pioneering advances in biotechnology research and innovation, and millions of patients around the globe continue to benefit from the treatments developed by companies that are discovering, developing and delivering innovative medicines to treat serious illnesses. As companies continue to develop medicines that address significant unmet needs, future innovations in biotechnology research will bring exciting new advances to help millions more people worldwide.

THE AMGEN SCHOLARS WEBSITE ADDS AN
EXCLUSIVE COMMUNITY TO BUILD A GLOBAL
NETWORK OF SCIENTISTS
Amgen Scholars will have exclusive access to the online Amgen Scholars
Community (www.amgenscholars.com), where they can keep in touch with one another, make new connections, and maintain the excitement and momentum of the program long after their summer lab experiences come to a close.
The new website, launched in partnership with The Scientist , a leading life sciences magazine, allows current Amgen Scholars and alumni to log in and access tools aimed at helping them to build professional networks and read the latest science and career news. Through the use of interactive polls, message boards, personal profiles and blogs, users can discuss their participation in the program and various science-related topics, such as graduate education and career paths in research. Others interested in the program can also view past participant and faculty mentor profiles, and read excerpts of student blogs from the online community in the publicly accessible section of the site.
Additionally, the Scholars can create their own profiles with their names and photographs, and provide updates on their current educational status.
Similar to other networking sites, the Scholars can “friend” one another, post comments on one another’s “walls,” participate in polls and communicate through instant messaging.
With over 800 students completing the Amgen Scholars Program since the first summer in 2007, this special members-only section will evolve into a close-knit global networking site where Scholars can continue to share their passion for science going forward.
On the public site, visitors will find an overview of the Amgen Scholars
Program and its objectives, a list of the 10 U.S. and three European host universities with links to their specific program descriptions and the key areas of academic research offered. They can also view past photos of the symposia where all Scholars gather to hear firsthand from leading industry and academic scientists, network with one another and discuss their summer research projects.
The site also features a special Learn About Biotechnology section that touches on biotechnology basics and historical milestones, along with sections on genes, DNA structure, the genetic code, DNA, RNA and proteins, the backbone of biotechnology, recombinant DNA – and a look toward the future.
“The new website is designed to connect, engage and inspire Amgen
Scholars on a global level by bringing together participants from diverse backgrounds and wide-ranging scientific career aspirations,” says
Christopher Jones, director, U.S. Program Office. “We hope that this site will enrich the experience for all participants – not only during their participation in the program, but throughout their careers in science.”
DID YOU KNOW:
3

4
A R E A S O F R E S E A R C H
Biochemistry
Bioengineering
Bioinformatics
Biopsychology
Biotechnology
Chemical & Biomolecular
Engineering
Chemistry
Immunology
Medical Pharmacology
Microbiology
Molecular, Cell &
Developmental Biology
Molecular Genetics
Molecular Medicine
Molecular Pharmacology
Neurobiology
Neuroscience
Pathology
Physiological Psychology
Physiological Science
Statistics
Toxicology
“By 2010, we’ll have more than 1,000
Amgen Scholar alumni in the United States and Europe. Several from the first class are now pursuing PhDs and MD-PhDs at top universities, and several have received prestigious fellowships. The Amgen Scholars
Program is central to our investments in science education and one of the many ways we hope to inspire and prepare the next generation of scientists.”
– Jean Lim, President,
Amgen Foundation
Biology, biochemistry, bioengineering – these are the most popular areas of interest among the 329 undergraduates who spent the summer working under the guidance of top academic scientists in leading labs across the United States and Europe.
The students were part of a hands-on science and biotechnology research experience available only through the Amgen Scholars Program.
They arrived at their labs each morning and, for the next eight to 10 weeks, spent their days focused on scientific discovery.
Launched in October 2006, the Amgen Scholars Program offers students the chance to participate in science beyond the likely scope of their regular undergraduate education. The program offers financial support to broaden access to all students who want to participate.
In 2009, the Amgen Foundation and 13 host universities welcomed 270
U.S. students and, new this year, 59 students from across Europe, selected from 2,800 applicants. The Amgen Scholars represented over 170 colleges and universities across 39 U.S. states and 15 European countries.
The Amgen Scholars Program is proving to be pivotal in inspiring students to pursue graduate training and scientific careers. Students call the program a challenging and often life-changing experience.

UC Berkeley Amgen Scholars participate in the end-of-program poster and oral presentations.
Amgen Scholars across all 13 host universities present their research through similar events at their respective institutions.
DID YOU KNOW:
CARL J. SUNDBERG, MD, PhD
ASSOCIATE PROFESSOR, KAROLINSKA INSTITUTET
As an expert in muscle physiology, Dr. Carl Johan Sundberg,
MD, PhD, of Stockholm’s Karolinska Institutet, devotes his scientific career to researching and understanding the health benefits of physical activity. The more discoveries
Dr. Sundberg and his team can make, the better they can help prevent diabetes, cardiovascular disease and more.
Their work has limited meaning, however, unless the results are widely communicated with medical practitioners and the population at large. That’s what inspired Dr. Sundberg to create the Euroscience Open Forum (ESOF). Held every two years, ESOF attracts more than 5,000 scientists, policymakers, journalists and others who come to hear and discuss new scientific findings.
One budding scientist hoping to attend the 2010 gathering in Barcelona is Maria Sobczyk. An Amgen Scholar from
Poland, Sobczyk is a biology major at the University of York in the United Kingdom.
She spent the summer in Dr. Sundberg’s lab, comparing the transcription of mitochondrial biogenesis factors in human skeletal muscle during acute and endurance exercise.
The results of her work have potential use in treating patients with type 2 diabetes, and cardiac insufficiency.
“Maria developed a strong understanding of the basic mechanisms for health, which translate into preventive or curative measures,” Dr. Sundberg says. “I hope Maria became even more excited about science – not just by experiencing how science can be done, but by seeing the direct effect it has on patients.”
Sobczyk was particularly pleased with the program, which was in its first summer at Karolinska Institutet.
“The program was a perfect way for me to see what it would be like to work full time as a scientist,” says
Sobczyk. “I learned how to be methodical and critical, how to design experiments and the appropriate times to draw conclusions. I also loved being around other students from throughout Europe.”
“Offering summer research experiences through the
Amgen Scholars Program is a new idea for Europe – and it’s a great way to bring young people into the lab,” says
Dr. Sundberg.
A professor of bioentrepreneurship as well as physiology and pharmacology at the Karolinska
Institutet in Sweden, Dr. Carl
Johan Sundberg served as a faculty mentor during the first year of the Amgen Scholars
Program in Europe.
5

C A L I F O R N I A I N S T I T U T E
O F T E C H N O L O G Y
Pasadena, CA
26 Scholars from
14 Universities across
8 States
C O L U M B I A
U N I V E R S I T Y /
B A R N A R D C O L L E G E
New York, NY
29 Scholars from
12 Universities across
8 States
H O W A R D U N I V E R S I T Y
Washington, D.C.
20 Scholars from
13 Universities across
11 States
M A S S A C H U S E T T S
I N S T I T U T E O F
T E C H N O L O G Y
Cambridge, MA
27 Scholars from
16 Universities across
12 States
6
U N I V E R S I T Y O F
C A L I F O R N I A ,
S A N D I E G O
San Diego, CA
30 Scholars from
16 Universities across
10 States
U N I V E R S I T Y O F
C A L I F O R N I A ,
S A N F R A N C I S C O
San Francisco, CA
29 Scholars from
27 Universities across
19 States
U N I V E R S I T Y O F
W A S H I N G T O N
Seattle, WA
29 Scholars from
22 Universities across
12 States and Puerto Rico
U N I V E R S I T Y O F
C A M B R I D G E
Cambridge, United Kingdom
25 Scholars from
15 Universities across
10 Countries

S TA N F O R D
U N I V E R S I T Y
Palo Alto, CA
30 Scholars from
27 Universities across
13 States and Puerto Rico
U N I V E R S I T Y O F
C A L I F O R N I A ,
B E R K E L E Y
Berkeley, CA
25 Scholars from
21 Universities across
14 States and Puerto Rico
U N I V E R S I T Y O F
C A L I F O R N I A ,
L O S A N G E L E S
Los Angeles, CA
25 Scholars from
12 Universities across
8 States
K A R O L I N S K A
I N S T I T U T E T *
Stockholm, Sweden
12 Scholars from
11 Universities across
9 Countries
L U D W I G - M A X I M I L I A N S -
U N I V E R S I T Ä T M U N I C H *
Munich, Germany
22 Scholars from
13 Universities across
11 Countries
* These organizations received a grant from the United Way Worldwide (UWW) in collaboration with the Amgen Foundation. The Amgen Foundation and UWW work together to support the efforts of nonprofit organizations outside of the United States.
7

SCHOLAR NAME: Jose Rios
UNDERGRADUATE INSTITUTION: Arizona State University
HOST INSTITUTION: Massachusetts Institute of Technology
HOMETOWN: Phoenix, Arizona, United States
MAJOR/DEGREE OBJECTIVE: Bioengineering
Jose Ruiz in the Langer Lab with Dr. Robert Langer of MIT.
8
To know Jose Rios, you’d think higher education was always in his plans. As a top high school student with a passion for science, he had certainly considered it. But Rios knew his family couldn’t afford the added expense. It wasn’t until his physics teacher connected him with the right scholarships that Rios realized college could, indeed, become a reality.
Now a senior at Arizona State University, Rios graduates in May 2010 with a bioengineering degree – the first in his family to earn a college diploma. And, thanks to guidance from a professor familiar with the Amgen
Scholars Program, the first in his family with MIT on his curriculum vitae.
Rios spent two months in the summer of 2009 as an Amgen Scholar in the prestigious lab of MIT Professor Robert Langer. His project: Targeting
Nanocarriers to Cancer with Folic Acid.
Rios spent his days synthesizing and transforming polymers into nanoparticles to improve their ability to target the disease.
Along with discovering new science, Rios says gaining hands-on lab experience was just as valuable. Everything he learned that summer, he says, was new. He enjoyed it all – even the challenges. “Sometimes you plan your experiments, but many times they don’t go right,” Rios says. “You troubleshoot and find out what’s wrong. And then you make corrections and you’re able to get good data. That feels good.”
He also enjoyed the U.S. Symposium in Los Angeles, where Scholars from across the country gathered to meet and network with one another, share their research, and hear from industry and academic scientists.
What’s after graduation? Rios had been thinking of pursuing science further or focusing on an MBA. The Amgen Scholars Program convinced him that his heart lies in the lab. He’s planning to apply to MIT to pursue his graduate degree in bioengineering.
“I knew that I liked science, but until I got that lab experience this summer, I didn’t know if I could make it a career,” he notes. “The Amgen
Scholars Program showed me that I could.”
“I’d like my work to have meaning to society,” Rios adds. “Through research and medicine, you really can better the lives of many people in ways that you’ve never imagined.”
Since returning to Arizona, Rios has continued his work with the Society of Hispanic Professional Engineers, visiting Phoenix-area elementary and middle school classrooms to speak about his experiences in science.
His message to students, especially those first-generation Americans of
Hispanic heritage: They, too, can and should go to college.

When Taiyabah Naeem learned about the Amgen Scholars Program and the chance to work in Dr. Anthony Ricci’s Otolaryngology lab at Stanford
University, she didn’t hesitate to apply.
Her summer project of observing the time course of aminoglycosides’ pathway entry into the channels of the inner ear cells was of special interest to her. Naeem, a dual biology and chemistry major at Gallaudet
University, has been deaf since birth.
“I wanted to be part of a research group committed to helping people and learning more about how the inner ear works,” says Naeem. “Being a deaf person myself, it was intriguing to learn more about the ear and its structure and function. Knowing that our research project could possibly impact thousands of hearing-impaired people is pretty amazing.”
Aminoglycosides are antibiotics used to treat bacterial infections.
However, because they’re toxic, they can cause permanent hearing loss.
Naeem’s research supported the hypothesis that aminoglycosides enter the hair cell through MET channels, which increase the antibiotics’ toxicity. Her findings suggest that aminoglycosides should be redesigned for safer entry into the inner ear, thereby avoiding the potential for hearing impairment.
Perhaps not surprisingly, one of the most challenging aspects of the experience for Naeem was noticing what was going on around her
– especially in group meetings. Naeem found it challenging to catch signaling sounds during experiments, communicate in dark rooms and understand those who spoke softly or with heavy accents.
“There is no doubt that being deaf in the field of science is an interesting and challenging experience,” she says. “But deaf people can definitely be trained in science if we are given the opportunity and support needed to succeed. Sometimes I think that being deaf works to my advantage because it hones my other senses, such as vision and smell.”
Prior to Amgen Scholars, Naeem was planning on medical school. Now she’s considering graduate-level research in hearing loss.
“Either way, I’m much more committed and prepared,” she says. “In general, I find that people are very willing to give me a chance to prove my abilities in science. Ultimately, I want to be a role model for other deaf people from varying backgrounds.”
Taiyabah Naeem in Dr. Anthony Ricci’s
Otolaryngology lab at Stanford University.
SCHOLAR NAME: Taiyabah Naeem
UNDERGRADUATE INSTITUTION: Gallaudet University
HOST INSTITUTION: Stanford University
HOMETOWN: Toronto, Canada
MAJOR/DEGREE OBJECTIVE: Biology and Chemistry
9

SCHOLAR NAME: Sophie Thomain
UNDERGRADUATE INSTITUTION: École Normale Supérieure
HOST INSTITUTION: University of Cambridge
HOMETOWN: Bidos, France
MAJOR/DEGREE OBJECTIVE: Bioengineering
Sophie Thomain in the Krude Lab with Dr.
Torsten Krude of the University of Cambridge.
10
As a third-year biology student at the prestigious École Normale
Supérieure in Paris, Sophie Thomain knew she was getting an excellent education, but she wanted to round out her undergraduate experience with extra lab work. She’d heard about the groundbreaking discoveries in Dr. Torsten Krude’s lab at the University of Cambridge, so she inquired about an internship.
Dr. Krude suggested something even better: the Amgen Scholars Program, which would provide support to assist with Thomain’s travel and living expenses and include a stipend, thus freeing her from financial worries over the summer.
“When he told me about the program, I couldn’t believe my luck,” Thomain says. “I immediately applied and couldn’t wait to get started.”
Thomain spent the summer in Dr. Krude’s lab, researching how DNA is replicated in human cells. She focused on a small RNA named hY RNA, which Dr. Krude’s team had discovered years earlier. Her task: to understand the role hY RNA plays in initiating DNA replication.
“Having a better understanding of this replication is important,” Thomain says. “If the replication is not done correctly, a cell can become cancerous.
This research is crucial in understanding carcinogenesis.”
By the end of the summer, Thomain and her team were able to show that a cell’s sensitivity to hY RNA is at the level of origin itself, and not at the global level. “That’s very fundamental research, but all knowledge is important in understanding DNA replication,” she says.
For Thomain, the Amgen Scholars Program offered far more than valuable lab lessons. It allowed her to collaborate with colleagues during a threeday symposium in which all Amgen Scholars across Europe participated.
“We acquire experience not only from the experiments in test tubes, but also from working together as a scientific community,” Thomain says. “I enjoyed being together in the same place and sharing our difficulties, doubts and successes. We learned how to communicate our results – and our lack of results! It’s more than a lab experience. It’s a human experience.”
Did the program make a difference in her career plans? Thomain shares an enthusiastic yes.
“I definitely want to spend more time in the laboratory because I like designing my own experiments – and I really enjoy working in a team,” she says. “The Amgen Scholars Program has inspired me to keep pursuing my studies right through to my PhD, and even beyond.”

When Taylor Lenton learned that Dr. John D. Roberts was accepting
Amgen Scholars to his California Institute of Technology (Caltech) lab, she knew right away where she wanted to spend her 2007 summer break.
Then a junior chemistry major at Wellesley College, Lenton identified
Caltech as one of her top graduate school choices. She had heard of Dr.
Roberts’ groundbreaking work with nuclear magnetic resonance (NMR) spectroscopy, and was attracted to the unique information that could be gained from this type of research.
“The possible applications for the research piqued my interest, and definitely motivated me to try something new,” says Lenton. “Plus, I wanted to spend some time at Caltech to make sure it was the right place for me to continue my education.”
Lenton certainly got her chance to do both. She spent 10 weeks in
Dr. Roberts’ lab suspending samples of ß-alanine, a small molecule, in different solutions and using the NMR to observe how the molecule’s movement was changed.
After graduating from Wellesley in 2008, Lenton returned to Caltech in the fall as a graduate student, just as she’d planned. She now works in Dr. John Bercaw’s lab, specializing in organometallics – a field that combines aspects of inorganic and organic chemistry. There she works on designing new metal-based catalysts for making polypropylene.
She often stops by Dr. Roberts’ lab to see how the project is going.
“Science only progresses so quickly,” Lenton says. “And often, you’ll pursue one direction only to find that you need to approach things differently.
But that’s what I love about it. As soon as you solve one piece of the puzzle, you end up facing 15 other pieces. The more approaches that you can think about and pursue, the better your ultimate result will be.”
“I still run into the Amgen Scholars I worked with that summer, as well as others who’ve been through the program at different sites. There’s an instant connection because we’re all really excited about science. It’s a great program. I’d recommend it to anyone,” Lenton says.
Taylor Lenton in Dr. John Bercaw’s lab at
Caltech where she works as a PhD student.
SCHOLAR NAME: Taylor Lenton
UNDERGRADUATE INSTITUTION: Wellesley College
HOST INSTITUTION: California Institute of Technology
GRADUATE INSTITUTION: California Institute of Technology
DEGREE PROGRAM: PhD, Chemistry
11

DID YOU KNOW:
CURRENT STATUS* OF THE 378 PROGRAM ALUMNI
WHO HAVE COMPLETED THEIR UNDERGRADUATE STUDIES
53
67
UNKNOWN
(18%)
SCIENCE-
BASED
CAREER
(14%)
54
MEDICAL
SCHOOL
(14%)
25 NON-SCIENCE GRADUATE
SCHOOL/CAREER (7%)
163
GRADUATE
SCHOOL IN
SCIENCE
(MASTER,
PhD)
(43%)
16 MD/PhD
PROGRAM (4%)
STUDENTS IN PhD/MASTER
PROGRAMS BY DISCIPLINE
6% BIOCHEMISTRY
13%
6%
BIOENGINEERING
BIOLOGY
5%
11%
BIOMEDICAL SCIENCE
CHEMISTRY
5% ENGINEERING
3%
9%
IMMUNOLOGY
MOLECULAR BIOLOGY
5% NEUROSCIENCE
4%
33%
PHARMACEUTICALS
SCIENCE (UNSPECIFIED)
NOTABLE ALUMNI ACHIEVEMENTS
JOYCE HWANG
HENRY RICHARDSON LABOUISSE ’26 PRIZE RECIPIENT
Host: University of Washington, 2007
Undergraduate: Princeton University
Current: Studying drug-resistant malaria in Thailand
JENNIFER YEH
CO-AUTHOR OF ARTICLE IN NATURE ON HOW MULTI-
GENETIC EVENTS COLLABORATIVELY CONTRIBUTE TO
PTEN-NULL LEUKAEMIA STEM-CELL FORMATION
Host: University of California, Los Angeles, 2007
Undergraduate: Massachusetts Institute of Technology
Graduate: George Washington University
MICHAEL FUNK
COMPLETED FELLOWSHIP AT MAX PLANCK INSTITUTE
FOR BIOPHYSICAL CHEMISTRY IN GERMANY
Host: California Institute of Technology, 2007
Undergraduate: Vanderbilt University
Graduate: Massachusetts Institute of Technology
TIMOTHY PARENTEAU
COMPLETED INTERNSHIP AS A TRANSLATIONAL
RESEARCH ASSISTANT AT THE MAYO CLINIC
Host: Stanford University, 2007
Undergraduate: California State University, Fullerton
Graduate: University of California, San Francisco
12
*Status as of Fall 2009. Note that 436 of the program’s 814 alumni are still pursuing their undergraduate studies and are not included in the pie chart above.

PARTICIPATION IN EUROPE BY UNDERGRADUATE AREA OF STUDY
OTHER (14%)
NATURAL
SCIENCE
(32%)
BIOLOGY
(22%)
* Total may exceed 100% as some participants identified more than one area of study.
MEDICAL SCIENCE (5%)
NEUROSCIENCE (5%)
PHYSIOLOGY (5%)
BIOTECHNOLOGY
(7%)
BIOCHEMISTRY
(8%)
BIOMEDICAL
SCIENCE (8%)
1
FINLAND
1
SWEDEN
KAROLINSKA INSTITUTET
SWEDEN
2
IRELAND
25
UNITED
KINGDOM
UNIVERSITY OF CAMBRIDGE
UNITED KINGDOM
3
SPAIN
2
GERMANY
6
POLAND
4
FRANCE
1
SWITZERLAND
LUDWIG-MAXIMILIANS-UNIVERSITÄT MUNICH
GERMANY
2
CROATIA 1
BOSNIA &
HERZEGOVINA
1
GREECE
2
SERBIA
7
TURKEY
1
RUSSIA
LIST OF 2009 EUROPEAN PARTICIPANTS’ HOME INSTITUTIONS
BOSNIA
International University of Sarajevo
CROATIA
University of Zagreb
FINLAND
University of Helsinki
FRANCE
École Normale Supérieure
University of Paris VI,
Pierre et Marie Curie
GERMANY
Jacobs University Bremen
GREECE
University of Athens
IRELAND
University College Cork
University College Dublin
POLAND
Jagiellonian University
Medical University of Gdansk
Poznan University of
Medical Sciences
University of Warsaw
RUSSIA
St. Petersburg State University
SERBIA
University of Belgrade
SPAIN
Universidad Autónoma de Barcelona
Universidad Autónoma de Madrid
University of Seville
SWEDEN
Karolinska Institutet
SWITZERLAND
Swiss Federal Institute
of Technology, Lausanne
TURKEY
Bilkent University
Bogaziçi University
Fatih University
Izmir Institute of Technology
UNITED KINGDOM
Durham University
Edinburgh University
Imperial College London
King’s College London
Queen Margaret University, Edinburgh
University College London
University of Cambridge
University of Glasgow
University of Nottingham
University of Oxford
University of Sussex
University of York
*Map is based on the 2009 European participants’ home institutions.
13

UNIVERSITY OF
WASHINGTON
13
WA
1
MT
2
OR
6
MN
2
ID
2
WY
2
IA
UC SAN FRANCISCO
UC BERKELEY
STANFORD
CALTECH
UC LOS ANGELES
UC SAN DIEGO
70
CA
3
UT
2
CO
2
MO
1
AZ
2
NM
1
OK
3
LA
7
TX
DID YOU KNOW:
14
LIST OF 2009 U.S. PARTICIPANTS’ HOME INSTITUTIONS
AL
Stillman College
University of Alabama at Birmingham
AZ
Arizona State University
CA
California Institute of Technology
California State University, Los Angeles
California State University,
Monterey Bay
California State University, Northridge
Chapman University
Occidental College
Pitzer College
San Diego State University
Scripps College
University of California, Berkeley
University of California, Davis
University of California, Irvine
University of California, Los Angeles
University of California, Riverside
University of California, San Diego
University of California, Santa Barbara
University of California, Santa Cruz
University of Southern California
CO
University of Colorado, Boulder
Western State College of Colorado
CT
Yale University
DC
Gallaudet University
Howard University
DE
University of Delaware
FL
Barry University
Florida International University
Florida State University
University of Florida
University of South Florida
GA
Emory University
Morehouse College
Spelman College
University of Georgia
IA
Iowa State University
University of Iowa
ID
College of Idaho
University of Idaho
IL
Knox College
Loyola University, Chicago
University of Chicago
University of Illinois, Chicago
University of Illinois,
Urbana-Champaign
IN
Goshen College
KY
Transylvania University
University of Kentucky
LA
Louisiana State University
Tulane University
Xavier University of Louisiana
NOTE: All data for the Amgen Scholars Program is collected and evaluated externally through the Center for Evaluation and Education Policy (CEEP) at Indiana University.
2
WI
5
IL
2
MS

PARTICIPATION IN THE U.S. BY UNDERGRADUATE AREA OF STUDY
OTHER
(25%)
1
IN
2
AL
6
MI
10
OH
2
PA
1
VA
9
MD
29
NY
9
DC
3
NJ
1
DE
1
CT
29
MA
1
NH
5
RI
MASSACHUSETTS
INSTITUTE OF
TECHNOLOGY
COLUMBIA UNIVERSITY
HOWARD UNIVERSITY
BIOLOGY
(42%)
BIOCHEMICAL ENGINEERING/
CHEMICAL ENGINEERING (6%)
NEUROSCIENCE AND BEHAVIOR (7%)
CHEMISTRY (11%)
BIOENGINEERING/BIOMEDICAL ENGINEERING (13%)
BIOCHEMISTRY (15%)
* Total may exceed 100% as some participants identified more than one area of study.
2
TN
3
KY
5
GA
2
SC
10
FL
5
NC
6
PR
MA
Amherst College
College of the Holy Cross
Franklin W. Olin College of Engineering
Massachusetts Institute of Technology
Mount Holyoke College
Smith College
University of Massachusetts, Amherst
Williams College
MD
McDaniel College
Prince George Community College
Saint Mary’s College of Maryland
University of Maryland,
Baltimore County
University of Maryland, College Park
MI
Kalamazoo College
Michigan State University
Michigan Technological University
University of Michigan, Ann Arbor
University of Michigan, Flint
MN
Carleton College
College of Saint Scholastica
Gustavus Adolphus College
Macalester College
Minnesota State University, Mankato
University of St. Thomas, St. Paul
MO
Missouri State University
Washington University, St. Louis
MS
Alcorn State University
Tougaloo College
MT
Montana Tech of
The University of Montana
NC
Davidson College
Duke University
Elon University
University of North Carolina,
Chapel Hill
NH
University of New Hampshire
NJ
Montclair State University
Rutgers University
The College of New Jersey
NM
University of New Mexico
NY
Barnard College
Columbia University
Cornell University
Hunter College
New York University
Rensselaer Polytechnic University
Saint Joseph’s College
State University of New York, Albany
State University of New York,
Binghamton
State University of New York, Buffalo
State University of New York,
Stony Brook
Syracuse University
OH
Denison University
Kenyon College
Oberlin College
Ohio State University
Ohio University
Ohio Wesleyan University
Xavier University
OK
University of Oklahoma
OR
Oregon State University
Willamette University
PA
Temple University
University of Pennsylvania
RI
Brown University
University of Rhode Island
SC
Allen University
Benedict College
TN
Tennessee Technological University
Vanderbilt University
TX
Baylor University
Rice University
Saint Edwards University
University of Houston
University of Houston, Clear Lake
University of Texas, El Paso
UT
Brigham Young University
VA
Norfolk State University
WA
Eastern Washington University
University of Washington
Whitman College
Whitworth University
WI
Lawrence University
University of Wisconsin, Madison
WY
University of Wyoming
PUERTO RICO
University of Puerto Rico, Mayagüez
University of Puerto Rico, Río Piedras
*Map is based on the 2009 U.S. participants’ home institutions.
15

16
“We are in a time of remarkable evolution of what is possible, and it is wondrous to imagine what is available to you.”
With those inspiring words, Joseph Miletich, Amgen’s senior vice president, Research & Development, and member, Amgen Foundation
Board of Directors, kicked off the third Amgen Scholars U.S. Symposium,
July 18–20, at UC Los Angeles. He spoke again September 16–18, at
Cambridge University, for the Amgen Scholars European Symposium.
During the three days, students share their summer research projects from top academic laboratories around the world, network with leading scientists in industry and academia, and hear presentations that aim to inspire them to pursue graduate studies and scientific careers.
At the U.S. symposium, Dr. Charles Craik, professor of biochemistry, pharmaceutical chemistry, and cellular and molecular pharmacology at
UC San Francisco, talked about various career paths open to scientists with PhDs. Amgen scientists – including Brian Kotzin, vice president of
Medical Sciences; Michael Ominsky, principal scientist in Research; and
David Reese, executive director of Global Development – highlighted the various stages of the drug discovery and development process – from identifying drug targets to the evolution of protein therapeutics. Alison
Moore, vice president of commercial manufacturing, spoke about the process of manufacturing therapeutic proteins.
Plus, more than 30 Amgen and other scientists and engineers hosted roundtable and panel discussions, giving students an insider’s view of a day in the life of a scientist. More than 40 faculty and staff from the host universities were on hand to help facilitate discussions of research projects.
A new career opportunities panel was added this year and included
Richard Gallagher, editor and publisher of The Scientist magazine. The overriding message from this panel: Consider all avenues that present themselves and try to combine your personal interests into your engagement with science.
Owen Witte, professor of microbiology, immunology and molecular genetics and director of the Eli and Edythe Broad Center of Regenerative
Medicine and Stem Cell Research at UCLA, concluded the symposium by sharing the findings of his latest cancer research – work he has advanced through a consortium of top academic researchers representing a number of disciplines.

At the European Symposium in Cambridge, Scholars heard welcoming remarks from Cambridge Professor Tony Minson, director of the Amgen
Scholars European Coordinating Center, and Jean Lim, president of the
Amgen Foundation.
Students then heard keynote addresses from Amgen’s Joseph Miletich and Tom Blundell, Sir William Dunn Professor of Biochemistry at the University of Cambridge, about the impact of biotechnology on drug discovery and development from both the industry and academic perspective.
A session on practical applications of research featured speakers from both the University of Cambridge and Amgen. Another session focused on “Lives in Science” and included Ken Smith, Genzyme Professor of
Experimental Medicine, University of Cambridge; Amgen’s Ulrike Schindler, executive managing director, Research; David Dunne, professor of
Parasitology, Department of Pathology, University of Cambridge; and biotechnology entrepreneur Andy Richards.
The European Symposium also included a visit to the Wellcome Trust
Sanger Institute, one of the leading genomics centers in the world, as well as roundtable discussions and poster sessions.
PARTICIPATION BY GENDER
(U.S. AND EUROPE)
60%
FEMALE
40%
MALE
BREAKDOWN BY SUMMER RESEARCH
DISCIPLINE (U.S. AND EUROPE)
8%
7%
3%
BIOCHEMISTRY
BIOENGINEERING
CHEMICAL AND
BIOMOLECULAR ENGINEERING
7%
9%
24%
CHEMISTRY
IMMUNOLOGY
MOLECULAR, CELL AND
DEVELOPMENTAL BIOLOGY
16%
7%
3%
5%
7%
4%
MOLECULAR GENETICS
MOLECULAR PHARMACOLOGY
NEUROBIOLOGY
NEUROSCIENCE
OTHER
TOXICOLOGY

Amgen Foundation
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 www.amgen.com
Massachusetts Institute of Technology
77 Massachusetts Avenue
Cambridge, MA 02139-4307 web.mit.edu
The Old Schools
Trinity Lane
Cambridge CB2 1TN, UK www.cam.ac.uk
DESIGN: Saputo Design Inc. PHOTOGRAPHY: Eileen Barroso, Steve Fisch, Warren Goebbels, Richard Harbaugh, Barry Hetherington, Andrew Houston, Timothy Llewellyn, Bob Paz, Tony Rinaldo,
Peg Skorpinski, Bob Stevens, Stefan Zimmerman WRITER: Mary Thorsby PRINTING: Universal Millennium EDITING: Linda Walsh